Skip to content
10-Q

Quarterly Report

Oyster Point Pharma, Inc.

0001720725-22-000080

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 4, 2022 26.84M sh
Shares Diluted Q3 2022 · Sep 30, 2022 26.83M sh
Shares Diluted Q3 2022 · Sep 30, 2022 26.74M sh
Shares Diluted Q3 2022 · Sep 30, 2021 26.04M sh
Shares Diluted Q3 2022 · Sep 30, 2021 25.98M sh
Capex Q3 2022 · Sep 30, 2022 $203K
Capex Q3 2022 · Sep 30, 2021 $1.25M
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$124.51M
Operating Cash Flow restated Q3 2022 · Sep 30, 2021 −$47.88M
Long Term Debt Q3 2022 · Sep 30, 2022 $92.22M
Long Term Debt Q3 2022 · Dec 31, 2021 $89.82M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $68.8M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $193.37M
Cash And Equivalents Q3 2022 · Sep 30, 2021 $184.17M
Stockholders Equity Q3 2022 · Sep 30, 2022 −$22.2M
Stockholders Equity Q3 2022 · Jun 30, 2022 $10.78M
Stockholders Equity Q3 2022 · Mar 31, 2022 $55.99M
Stockholders Equity Q3 2022 · Dec 31, 2021 $99.54M
Stockholders Equity Q3 2022 · Sep 30, 2021 $137.51M
Stockholders Equity Q3 2022 · Jun 30, 2021 $151.78M
Stockholders Equity Q3 2022 · Mar 31, 2021 $170.65M
Stockholders Equity Q3 2022 · Dec 31, 2020 $186.66M
Current Liabilities Q3 2022 · Sep 30, 2022 $29.2M
Current Liabilities Q3 2022 · Dec 31, 2021 $28.8M
Total Liabilities Q3 2022 · Sep 30, 2022 $131.4M
Total Liabilities Q3 2022 · Dec 31, 2021 $123.08M
Current Assets Q3 2022 · Sep 30, 2022 $97.71M
Current Assets Q3 2022 · Dec 31, 2021 $215.25M
Total Assets Q3 2022 · Sep 30, 2022 $109.2M
Total Assets Q3 2022 · Dec 31, 2021 $222.62M
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.37
Eps Diluted Q3 2022 · Sep 30, 2022 −$5.03
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.68
Eps Diluted Q3 2022 · Sep 30, 2021 −$2.25
Eps Basic Q3 2022 · Sep 30, 2022 −$1.37
Eps Basic Q3 2022 · Sep 30, 2022 −$5.03
Eps Basic Q3 2022 · Sep 30, 2021 −$0.68
Eps Basic Q3 2022 · Sep 30, 2021 −$2.25
Sga Expense Q3 2022 · Sep 30, 2022 $12.15M
Sga Expense Q3 2022 · Sep 30, 2022 $39.08M
Sga Expense restated Q3 2022 · Sep 30, 2021 $10.33M
Sga Expense restated Q3 2022 · Sep 30, 2021 $27.94M
Rd Expense Q3 2022 · Sep 30, 2022 $3.91M
Rd Expense Q3 2022 · Sep 30, 2022 $13.26M
Rd Expense Q3 2022 · Sep 30, 2021 $6.21M
Rd Expense Q3 2022 · Sep 30, 2021 $18.77M
Net Income Q3 2022 · Sep 30, 2022 −$36.75M
Net Income Q3 2022 · Sep 30, 2022 −$134.58M
Net Income Q3 2022 · Jun 30, 2022 −$49.94M
Net Income Q3 2022 · Mar 31, 2022 −$47.89M
Net Income Q3 2022 · Sep 30, 2021 −$17.67M
Net Income Q3 2022 · Sep 30, 2021 −$58.6M
Net Income Q3 2022 · Jun 30, 2021 −$22.02M
Net Income Q3 2022 · Mar 31, 2021 −$18.91M
Operating Income Q3 2022 · Sep 30, 2022 −$33.91M
Operating Income Q3 2022 · Sep 30, 2022 −$119.51M
Operating Income Q3 2022 · Sep 30, 2021 −$16.77M
Operating Income Q3 2022 · Sep 30, 2021 −$57.71M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $1.35M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $2.99M
Cost Of Revenue Q3 2022 · Sep 30, 2021 $0
Cost Of Revenue Q3 2022 · Sep 30, 2021 $0
Revenue Q3 2022 · Sep 30, 2022 $5.59M
Revenue Q3 2022 · Sep 30, 2022 $12.99M
Revenue restated Q3 2022 · Sep 30, 2021 $0
Revenue restated Q3 2022 · Sep 30, 2021 $0